Folotyn User Reviews & Ratings
Folotyn has an average rating of 1.0 out of 10 from a total of 1 reviews on Drugs.com. 0% of reviewers reported a positive experience, while 100% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Peripheral T-cell Lymphoma | 1 reviews for Peripheral T-cell Lymphoma | 3 medications |
See also:
Beleodaq
Beleodaq (belinostat) interferes with the growth and spread of cancer cells in the body and is used ...
Istodax
Istodax is used to treat T-cell lymphoma affecting the skin. Learn about side effects, interactions ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Alimta
Alimta is used to treat non-small cell lung cancer and mesothelioma, a form of lung cancer ...
Arranon
Arranon is used to treat T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma ...
Clolar
Clolar is a cancer medicine that is used to treat acute lymphoblastic leukemia (a type of blood ...
Dacogen
Dacogen (decitabine) is used to treat myelodysplastic syndromes (certain types of blood or bone ...
Gemzar
Gemzar is used to treat cancers of the pancreas, lung, breasts and ovaries. Learn about side ...
Are you taking this medicine?
Your review helps others make informed decisions.More about Folotyn (pralatrexate)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: antimetabolites
- En español
For Peripheral T-cell Lymphoma "My wife had two weekly treatments and developed a high fever, low blood counts, weakness, and confusion and was unable to continue. 15 days in the hospital to come back to previous condition. As there were other issues involved, Folotyn was not determined to be the sole cause of her problems. We waited 9 weeks and tried another treatment of Folotyn, one week later we were back in the hospital for 12 days. This has not been a viable treatment for her as it has also had no effect on her PTCL NOS. We will most likely be trying Istodax next."